Font Size: a A A
Keyword [TKIs]
Result: 1 - 20 | Page: 1 of 10
1. Detection Of Epidermal Growth Factor Receptor Gene Mutations In Non - Small Cell Lung Cancer Tissues And Plasma By DPO - QPCR Method
2. Study On The Relationship Between ID1 And Non - Small Cell Lung Cancer
3. The Effects Of Combined Administration Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Cytotoxic Drugs In Different Tumor Cell Lines
4. Investigation On Molecular Mechanism Of Quickly Acquired Resistance To EGFR-TKIs Mediated By FGF-2Signaling Pathway
5. The APE1-mediated IL-6/STAT3 Signaling Pathway Regulates Chemosensitivity To CDDP In Nsclc A549 Cells
6. Molecular Mechanism Of The EGFR Inhibitor 244-MPT Overcomes Gefitinib Resistance In Non-small Cell Lung Cancer Cells
7. Development Of EGFR-TKIs Drug-Resistant NSCLC Cell Lines In Vitro And Investigation On The EGFR-TKIs Resistance Mechanism
8. Meta Analysis And Clinical Research Of Traditional Chinese Medicine (TCM) On Tyrosine Kinase Inhibitors (TKIs)- Induced Skin Toxicities
9. Construction And Identification Of Anti-EGFR Single Chain Fragment Antibody(scFv)and Inhibits The Proliferation Of NSCLC Cells And Tumor Growth By ScFv-mediate SiRNA
10. Synergistic Interaction Between Sunitinib And Docetaxel Is Sequence Dependent In Human Non-small Cell Lung Cancer With EGFR TKIs-resistant Mutation
11. Biological Characteristics And EGFR-TKIs Response In Lung Adenocarcinoma Associated With The EGFR Mutation And Its Subtypes
12. Analyses Of EGFR And K-ras Gene Mutations In NSCLC Patients With Initial Treatment
13. The Role Of Filamin A On The Resistance To EGFR-TKIs In Non-small Cell Lung Cancer
14. Yin "clear Heat, Blood Detoxification Method For Treating Skin Rash Associated With Egfr Tkis - Clinical Studies
15. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor As Maintenance Therapy For Advanced Non-Small-Cell Lung Cancer: A Meta-analysis Of Randomized Controlled Trials
16. The Clinical Significance Of NSCLC Patients With Peripheral T Lymphocyte Subsets Expression After TKIs Treatment
17. Circulating DNA EGFR Mutation And The Targeting Therapy Response In Advanced NSCLC Patients
18. The Roles Of EMT And IGF-1R In The Acquired Resistance Of Non-small Cell Lung Cancer To Epidermal Growth Factor-tyrosine Kinase Inhibitors
19. The Detection Of Egfr And Emt, And Its Relationship With The Efficacy Of Egfr-Tkis As The Second Line Treatment In Advanced Nsclc
20. Clinical Observation Of70Patients With Brain Metastases
  <<First  <Prev  Next>  Last>>  Jump to